Cardinal Health Inc., Agrees To Pay $34 Million To Settle Claims That It Failed To Report Suspicious Sales Of Widely-Abused Controlled Substance
Oct 3rd 2008Drug InformationMedical Malpractice / Litigation
Cardinal Health Inc., one of the nation’s largest distributors of pharmaceutical drugs, has agreed to settle allegations that it violated federal reporting provisions relating to its handling of certain controlled substances regulated by the Drug Enforcement Administration (DEA). Under the agreement between the company and seven U.S.
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
